Pernix Therapeutics (PTX) – Analyst EPS View
-
UPDATE: Oppenheimer Downgrades Pernix Therapeutics (PTX) to Perform
-
Pernix Therapeutics (PTX) PT Trimmed to $14 at Brean Capital Amid Weak Q2
-
-
-
-
-
-
-
-
-
-
Back to PTX Stock Lookup